407634-05-3 Usage
General Description
1-(2-Methoxy-ethyl)-5-oxo-pyrrolidine-3-carboxylic acid is an organic compound with the molecular formula C8H13NO5. It is a derivative of pyrrolidine and contains a carboxylic acid functional group. 1-(2-METHOXY-ETHYL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID is commonly used as a building block in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It has shown potential in various medicinal applications, including as an anti-inflammatory, antiviral, and anticancer agent. Additionally, it has been studied for its potential role in the treatment of neurodegenerative diseases and other disorders. Overall, 1-(2-methoxy-ethyl)-5-oxo-pyrrolidine-3-carboxylic acid is a versatile and important chemical compound with diverse potential applications in the field of medicinal chemistry and drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 407634-05-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,7,6,3 and 4 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 407634-05:
(8*4)+(7*0)+(6*7)+(5*6)+(4*3)+(3*4)+(2*0)+(1*5)=133
133 % 10 = 3
So 407634-05-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H13NO4/c1-13-3-2-9-5-6(8(11)12)4-7(9)10/h6H,2-5H2,1H3,(H,11,12)
407634-05-3Relevant articles and documents
CYCLIC AMINE BASE-1 INHIBITORS HAVING A HETEROCYCLIC SUBSTITUENT
-
Page/Page column 31, (2008/06/13)
Disclosed are novel compounds of the formula (I)or a pharmaceutically acceptable salt or solvate thereof, wherein R1 is formula (I) X is -0-, -C(R14)2- or -N(R)-; Z is -C(R14)2- or -N(R)-; t is 0, 1, 2 or 3; each R and R2 is independently H, alkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, heterocycloalkylalkyl, alkenyl or alkynyl; each R14 is H, alkyl, alkenyl, alkynyl, halo, -CN, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, heterocycloalkylalkyl, -OR35, -N(R24)(R25)or -SR35; R41 is alkyl, cycloalkyl, -S02(alkyl), -C(O)-alkyl, -C(O)-cycloalkyl or -alkyl-NH-C(O)CH3; and the remaining variables are as defined in the specification. Also disclosed are pharmaceutical compositions comprising the compounds of formula I and methods of treating cognitive or neurodegenerative diseases with compounds of formula (I). Also disclosed are pharmaceutical compositions and methods of treatment comprising compounds of formula I in combination with other agents useful in treating cognitive or neurodegenerative diseases.
